Stereotactic radiotherapy for ultracentral lung tumours.
Fiche publication
Date publication
juillet 2023
Journal
Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique
Auteurs
Membres identifiés du Cancéropôle Est :
Pr ANTONI Delphine
Tous les auteurs :
Bourbonne V, Thureau S, Pradier O, Antoni D, Lucia F
Lien Pubmed
Résumé
Ultracentral (UC) lung lesions are generally defined by the presence of the tumour or the Planning Target Volume (PTV) abutting proximal bronchial tree (PBT) or the esophagus. Initial reports rose awareness regarding the potential toxicity of stereotactic body radiotherapy (SBRT) when delivered to UC lesions. Major concerns include necrosis, stenosis, and bleeding of the PBT. Technological improvements now enable the delivery of more accurate treatments, possibly redefining the historical "no-fly zone". In this review, studies focusing on the treatment of UC lesions with SBRT are presented. The narrow therapeutic window requires a multidisciplinary approach.
Mots clés
Cancer du poumon, Lung cancer, Radiothérapie stéréotaxique, Stereotactic radiotherapy, Tumeurs ultracentrales, Ultracentral tumour
Référence
Cancer Radiother. 2023 07 27;: